Janssen debuts schizophrenia awareness doc

Share this article:
Janssen debuts schizophrenia awareness doc
Janssen debuts schizophrenia awareness doc
Johnson & Johnson is back in the film game with Janssen's half-hour documentary Living with Schizophrenia: A Call for Hope and Recovery.

The unbranded film, which follows several young people with schizophrenia and their families, aims to lessen the fear and stigma associated with the condition. It debuted Friday in Washington, DC, and will be distributed through a series of community-based events, via advocacy groups and online at hopeandrecoveryfilm.com.

The film, said director Emily Abt, “highlights the stories that don't make the headlines – the stories of hope and promise.” Abt's grandmother struggled with schizophrenia.

Janssen's Risperdal and Invega franchises are indicated for the treatment of schizophrenia, and the company sponsored an earlier documentary on the topic. In 2007, J&J's Centocor unit sponsored “Innerstate” an hour-long documentary following a similar formula, following several young people struggling with autoimmune disorders. Centocor makes Remicade for rheumatoid arthritis, psoriasis and Crohn's Disease.
Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.